Taysha Gene Therapies, Inc.
NASDAQ:TSHA
2.21 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||||
Current Assets: | |||||||||||||||||||
Cash & Cash Equivalents
| 157.688 | 172.743 | 124.429 | 144.389 | 164.278 | 45.083 | 63.425 | 87.88 | 34.306 | 66.239 | 96.63 | 149.103 | 188.785 | 197.37 | 228.684 | 251.253 | 278.634 | 11.2 | 0 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 157.688 | 172.743 | 124.429 | 144.389 | 164.278 | 45.083 | 63.425 | 87.88 | 34.306 | 66.239 | 96.63 | 149.103 | 188.785 | 197.37 | 228.684 | 251.253 | 278.634 | 11.2 | 0 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 3.867 | 5.727 | 3.566 | 5.928 | 7.529 | 9.032 | 8.933 | 8.537 | 8.696 | 10.596 | 10.261 | 10.499 | 1.723 | 2.202 | 10.945 | 6.626 | 0.604 | 0.099 | 0 |
Total Current Assets
| 161.555 | 178.47 | 129.916 | 149.187 | 171.807 | 54.115 | 72.358 | 96.417 | 43.002 | 76.835 | 106.891 | 159.602 | 197.17 | 207.302 | 239.629 | 257.879 | 279.238 | 11.299 | 0 |
Non-Current Assets: | |||||||||||||||||||
Property, Plant & Equipment, Net
| 16.291 | 19.484 | 19.947 | 20.408 | 21.021 | 24.487 | 25.289 | 25.906 | 63.954 | 61.011 | 55.12 | 50.61 | 40.553 | 33.867 | 2.497 | 0.287 | 0.028 | 0.019 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.992 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 2.151 | 2.151 | 2.637 | 2.637 | 2.637 | 2.637 | 2.637 | 2.637 | 2.637 | 2.637 | 2.628 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 94.263 | 0 | 0 | 0 | 2.355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.371 | 2.439 | 0.985 | 0.985 | 0.304 | 0.304 | 1.316 | 3.953 | 1.875 | 1.849 | 1.328 | 1.107 | 0.691 | 0.691 | 0.703 | 0.715 | 0 | 0 | 0 |
Total Non-Current Assets
| 18.662 | 21.923 | 23.083 | 117.807 | 23.962 | 27.428 | 29.242 | 29.859 | 68.466 | 65.497 | 59.085 | 54.354 | 43.872 | 34.558 | 3.2 | 1.002 | 0.028 | 0.019 | 0 |
Total Assets
| 180.217 | 200.393 | 152.999 | 266.994 | 195.769 | 81.543 | 101.6 | 126.276 | 111.468 | 142.332 | 165.976 | 213.956 | 241.042 | 241.86 | 242.829 | 258.881 | 279.266 | 11.318 | 0 |
Liabilities & Equity: | |||||||||||||||||||
Current Liabilities: | |||||||||||||||||||
Account Payables
| 4.932 | 8.718 | 10.38 | 6.366 | 7.52 | 10.766 | 9.002 | 10.946 | 15.251 | 23.967 | 21.997 | 21.763 | 22.051 | 6.355 | 4.083 | 1.994 | 8.837 | 1.25 | 0 |
Short Term Debt
| 0 | 1.754 | 1.696 | 1.646 | 1.538 | 1.638 | 1.752 | 1.521 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.204 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 11.795 | 13.583 | 14.695 | 18.106 | 18.759 | 20.243 | 28.851 | 33.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.204 | 0 |
Other Current Liabilities
| 12.608 | 10.121 | 11.866 | 10.638 | 152.634 | 17.994 | 14.85 | 16.766 | 17.888 | 18.986 | 26.62 | 29.983 | 21.163 | 22.036 | 14.875 | 5.135 | 2.787 | 1.636 | 0 |
Total Current Liabilities
| 29.335 | 34.176 | 38.637 | 36.756 | 180.451 | 50.641 | 54.455 | 62.79 | 33.139 | 42.953 | 48.617 | 51.746 | 43.214 | 28.391 | 18.958 | 7.129 | 11.624 | 20.09 | 0 |
Non-Current Liabilities: | |||||||||||||||||||
Long Term Debt
| 17.751 | 55.969 | 59.011 | 59.461 | 57.649 | 57.882 | 58.089 | 58.407 | 63.269 | 63.189 | 63.138 | 63.092 | 54.419 | 26.209 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 18.953 | 2.951 | 6.212 | 0 | -2.355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 94.263 | 0 | 0 | 0 | 2.355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 44.334 | 1.38 | 1.502 | 1.577 | 3.832 | 3.922 | 4.004 | 4.13 | 3.934 | 3.48 | 3.496 | 3.735 | 3.015 | 0.765 | 0.999 | 0.45 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 62.085 | 57.349 | 60.513 | 155.301 | 64.432 | 68.016 | 62.093 | 62.537 | 67.203 | 66.669 | 66.634 | 66.827 | 57.434 | 26.974 | 0.999 | 0.45 | 8.837 | 1.25 | 0 |
Total Liabilities
| 91.42 | 91.525 | 99.15 | 192.057 | 244.883 | 118.657 | 116.548 | 125.327 | 100.342 | 109.622 | 115.251 | 118.573 | 100.648 | 55.365 | 19.957 | 7.579 | 11.624 | 20.09 | 0 |
Equity: | |||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.014 | 0 |
Common Stock
| 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings
| -583.52 | -557.996 | -537.068 | -513.007 | -560.748 | -443.661 | -419.063 | -401.441 | -345.94 | -319.633 | -285.76 | -235.649 | -185.263 | -134.076 | -93.15 | -61.126 | -42.808 | -27.766 | 0 |
Accumulated Other Comprehensive Income/Loss
| -2.328 | 2.405 | -0.251 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | -0 | -0.135 |
Other Total Stockholders Equity
| 674.643 | 664.457 | 591.166 | 587.942 | 511.632 | 406.546 | 404.114 | 402.389 | 357.065 | 352.342 | 336.485 | 331.032 | 325.657 | 320.571 | 316.022 | 312.428 | 310.45 | 18.994 | 0 |
Total Shareholders Equity
| 88.797 | 108.868 | 53.849 | 74.937 | -49.114 | -37.114 | -14.948 | 0.949 | 11.126 | 32.71 | 50.725 | 95.383 | 140.394 | 186.495 | 222.872 | 251.302 | 267.642 | -8.772 | -0.135 |
Total Equity
| 88.797 | 108.868 | 53.849 | 74.937 | -49.114 | -37.114 | -14.948 | 0.949 | 11.126 | 32.71 | 50.725 | 95.383 | 140.394 | 186.495 | 222.872 | 251.302 | 267.642 | -8.772 | -0.135 |
Total Liabilities & Shareholders Equity
| 180.217 | 200.393 | 152.999 | 266.994 | 195.769 | 81.543 | 101.6 | 126.276 | 111.468 | 142.332 | 165.976 | 213.956 | 241.042 | 241.86 | 242.829 | 258.881 | 279.266 | 11.318 | -0.135 |